METHODS	40 healthy non-responder children to primary HB vaccination identified by screening were given a three-dose revaccination randomly by intramuscular ( n = 17 , 10 microg per dose ) or intradermal route ( n = 23 , 2 microg per dose ) since September , 1999 , and their blood specimens were collected regularly for testing for HB virus markers up to five years .\